The Drug Rediscovery Protocol (DRUP Trial)

Abroad (travel likely)RecruitingPHASE2

Conditions

Cancer · Tumors · Neoplasm · Neoplasia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Noordwest ziekenhuisgroep Alkmaar (NWZ), Alkmaar, Netherlands
Contact: Study coordinator (M.P. Hendriks, MD, PhD)
Contact: Principal Investigator (M.P. Hendriks, MD, PhD)
Ziekenhuisgroep Twente, Almelo, Netherlands
Contact: Study coordinator (E. Siemerink)
Contact: Principal Investigator (E. Siemerink)
Meander medisch centrum, Amersfoort, Netherlands
Contact: Study coordinator (G.A. Cirkel, MD)
Contact: Principal Investigator (G.A. Cirkel, MD)
Netherlands Cancer Institute, Amsterdam, Netherlands
Contact: Study coordinator (E.E. Voest, prof.) · DRUP@nki.nl · 0031205129111
Contact: Study coordinator (K Verkerk, MD) · DRUP@nki.nl · 0031205129111
Amsterdam UMC, locatie VUmc, Amsterdam, Netherlands
Contact: Study coordinator (M Labots)
Contact: Principal Investigator (M Labots)
Amsterdam UMC, locatie AMC, Amsterdam, Netherlands
Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, Netherlands
Contact: Study coordinator (E.D. Kerver)
Contact: Principal Investigator (E.D. Kerver)
Gelre ziekenhuizen, Apeldoorn, Netherlands
Contact: Study coordinator (S.C.S. Tromp)
Contact: Principal Investigator (S.C.S. Tromp)
Rijnstate ziekenhuis, Arnhem, Netherlands
Contact: Study coordinator (T. van Voorthuizen)
Contact: Principal Investigator (T. van Voorthuizen)
Amphia Ziekenhuis, Breda, Netherlands
Contact: Study coordinator (H. Westgeest, MD, PhD)
Contact: Principal Investigator (H. Westgeest, MD, PhD)
Reiner de Graaf Gasthuis, Delft, Netherlands
Contact: Study coordinator (A. Vulink)
Contact: Principal Investigator (A. Vulink)
Deventer ziekenhuis, Deventer, Netherlands
Contact: Study coordinator (A. Imholz)
Contact: Principal Investigator (A. Imholz)
Nij Smellinghe Ziekenhuis, Drachten, Netherlands
Contact: Study coordinator (S. Hovenga)
Contact: Principal Investigator (S. Hovenga)
Ziekenhuis Gelderse Vallei, Ede, Netherlands
Contact: Study coordinator (P. de Mol)
Contact: Principal Investigator (P. de Mol)
Maxima Medisch Centrum, Eindhoven, Netherlands
Contact: Study coordinator (G Vreugdenhil, MD, PhD)
Contact: Principal Investigator (G Vreugdenhil, MD, PhD)
Zuyderland medisch centrum, Geleen, Netherlands
Contact: Study coordinator (F.L.G. Erdkamp, MD)
Contact: Principal Investigator (F.L.G. Erdkamp, MD)
Rivas zorggroep, Gorinchem, Netherlands
Contact: Study coordinator (M.A. Davidis)
Contact: Principal Investigator (M.A. Davidis)
Martini ziekenhuis, Groningen, Netherlands
Contact: Study coordinator (J. van Rooijen)
Contact: Principal Investigator (J. van Rooijen)
University Medical Center Groningen, Groningen, Netherlands
Contact: Study coordinator (D.J.A. de Groot, MD, PhD)
Contact: Principal Investigator (D.J.A. de Groot, MD, PhD)
Spaarne gasthuis, Haarlem, Netherlands
Contact: Study coordinator (G.J. de Klerk)
Contact: Principal Investigator (G.J. de Klerk)
Tergooi MC, Hilversum, Netherlands
Contact: Study coordinator (H.P. van den Berg)
Contact: Principal Investigator (H.P. van den Berg)
Treant zorggroep, Hoogeveen, Netherlands
Contact: Study coordinator (C. Oldenhuis)
Contact: Principal Investigator (C. Oldenhuis)
Medisch Centrum Leeuwaarden, Leeuwarden, Netherlands
Contact: Study coordinator (H. de Graaf)
Contact: Principal Investigator (H. de Graaf)
Leiden University Medical Center, Leiden, Netherlands
Contact: Study coordinator (A.J. Gelderblom, MD, PhD)
Contact: Principal Investigator (A.J. Gelderblom, MD, PhD)
Maastricht University Medical Center, Maastricht, Netherlands
Contact: Study coordinator (A. Hoeben, MD, PhD)
Contact: Principal Investigator (A. Hoeben, MD, PhD)
St. Antonius ziekenhuis, Nieuwegein, Netherlands
Contact: Study coordinator (M. Los)
Contact: Principal Investigator (M. Los)
Radboud umc, Nijmegen, Netherlands
Contact: Study coordinator (C.M.L. van Herpen, MD, PhD)
Contact: Principal Investigator (C.M.L. van Herpen, MD, PhD)
Bravis ziekenhuis, Roosendaal, Netherlands
Contact: Study coordinator (S. Boudewijns)
Contact: Principal Investigator (S. Boudewijns)
St. Fransicus Gasthuis, Rotterdam, Netherlands
Contact: Study coordinator (A P Hamberg, MD)
Contact: Principal Investigator (A P Hamberg, MD)
Erasmus MC, Rotterdam, Netherlands
Contact: Study coordinator (M.J.A. de Jonge, MD, PhD)
Contact: Principal Investigator (M.J.A. de Jonge, MD, PhD)
Haaglanden medisch centrum, The Hague, Netherlands
Contact: Study coordinator (F. Jeurissen)
Contact: Principal Investigator (F. Jeurissen)
Haga ziekenhuis, The Hague, Netherlands
Contact: Study coordinator (D. Hautsma)
Contact: Principal Investigator (D. Hautsma)
Elisabeth-TweeSteden Ziekenhuis, Tilburg, Netherlands
Contact: Study coordinator (L.V. Beerepoot, MD, PhD)
Contact: Principal Investigator (L.V. Beerepoot, MD, PhD)
University Medical Center Utrecht, Utrecht, Netherlands
Contact: Study coordinator (L.A. Devriese, MD, PhD)
Contact: Principal Investigator (L.A. Devriese, MD, PhD)
VieCuri medisch centrum, Venlo, Netherlands
Contact: Study coordinator (Y. van der Wouw)
Contact: Principal Investigator (Y. van der Wouw)
Isala klinieken, Zwolle, Netherlands
Contact: Study coordinator (J.W.B. de Groot)
Contact: Principal Investigator (J.W.B. de Groot)

Study leads

E.E. Voest, prof.
Principal Investigator
The Netherlands Cancer Institute

View source on ClinicalTrials.gov Contact study team (email)